First-in-Human Trial in Healthy Adult Volunteers to Evaluate Safety, Tolerability and PK of LAPIX Study Drug; LPX-TI641
Clinical trial NCT05853835 · COMPLETED
Trial details
- NCT number
- NCT05853835
- Sponsor
- LAPIX Therapeutics Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-30
- Primary completion
- 2024-08-15
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.